NILUXA Trademark

Trademark Overview

On Monday, May 13, 2002, a trademark application was filed for NILUXA with the United States Patent and Trademark Office. The USPTO has given the NILUXA trademark a serial number of 78128305. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 9, 2012. This trademark is owned by Pfizer Inc.. The NILUXA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system diseases and disorders, neurological disorders

General Information

Serial Number78128305
Word MarkNILUXA
Filing DateMonday, May 13, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 9, 2012
Registration Number3077291
Registration DateTuesday, April 4, 2006
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 5, 2002

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of central nervous system diseases and disorders, neurological disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 9, 2012
Primary Code005
First Use Anywhere DateTuesday, November 22, 2005
First Use In Commerce DateTuesday, November 22, 2005

Trademark Owner History

Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Friday, November 9, 2012CANCELLED SEC. 8 (6-YR)
Wednesday, February 27, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 27, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 21, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 4, 2006REGISTERED-PRINCIPAL REGISTER
Thursday, February 23, 2006LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, February 17, 2006ASSIGNED TO LIE
Tuesday, February 14, 2006ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 1, 2006STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 11, 2006USE AMENDMENT FILED
Wednesday, January 11, 2006TEAS STATEMENT OF USE RECEIVED
Thursday, June 16, 2005EXTENSION 5 GRANTED
Thursday, June 16, 2005EXTENSION 5 FILED
Thursday, June 16, 2005TEAS EXTENSION RECEIVED
Friday, January 21, 2005EXTENSION 4 GRANTED
Wednesday, January 5, 2005EXTENSION 4 FILED
Wednesday, January 5, 2005TEAS EXTENSION RECEIVED
Wednesday, January 5, 2005ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 5, 2005TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 20, 2004EXTENSION 3 GRANTED
Friday, April 2, 2004EXTENSION 3 FILED
Friday, April 16, 2004CASE FILE IN TICRS
Friday, April 2, 2004PAPER RECEIVED
Wednesday, December 17, 2003EXTENSION 2 GRANTED
Monday, November 17, 2003EXTENSION 2 FILED
Monday, November 17, 2003PAPER RECEIVED
Wednesday, June 4, 2003EXTENSION 1 GRANTED
Thursday, May 1, 2003EXTENSION 1 FILED
Thursday, May 1, 2003TEAS EXTENSION RECEIVED
Tuesday, January 28, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 5, 2002PUBLISHED FOR OPPOSITION
Wednesday, October 16, 2002NOTICE OF PUBLICATION
Thursday, September 5, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 29, 2002ASSIGNED TO EXAMINER

Related Keywords

niluxa disorders diseases neurological system nervous preparations treatment central pharmaceutical